- Synergistic Induction of Apoptosis in Multiple Myeloma Cells by Bortezomib and Hypoxia-Activated Prodrug TH-302, In Vivo and In Vitro (vol 12, pg 1763, 2013)(2015)
Authors: Jinsong Hu, Els Van Valckenborgh, Dehui Xu, Eline Menu, Hendrik De Raeve, Elke De Bruyne, Song Xu, Benjamin Van Camp, Damian R Handisides, Charles P. Hart, et al.
Pages: 1762-1762
- IMWG consensus on risk stratification in multiple myeloma(2014)
Authors: Wj Chng, A Dispenzieri, C.s. Chim, Rik Schots, Benjamin Van Camp, Ivan Van Riet, Isabelle Vande Broek, Karin Vanderkerken
Pages: 269-277
- Upregulation of miR-135b is involved in the impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients(2013)
Authors: Song Xu, Gaia Santini, Kim De Veirman, Isabelle Vande Broek, Xavier Leleu, Ann De Becker, Benjamin Van Camp, Karin Vanderkerken, Ivan Van Riet
- Synergistic induction of apoptosis in multiple myeloma cells by bortezomib and hypoxia-activated prodrug TH-302, in vivo and in vitro.(2013)
Authors: Jinsong Hu, E Van Valckenborgh, Dehui Xu, Eline Menu, Hendrik De Raeve, Elke De Bruyne, Song Xu, Benjamin Van Camp, Damian R Handisides, Charles Hart, et al.
Pages: 1763-1773
- Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo(2013)
Authors: Song Xu, Kim De Veirman, Holly R. Evans, Gaia Santini, Isabelle Vande Broek, Xavier Leleu, Ann De Becker, Benjamin Van Camp, Peter I. Croucher, Karin Vanderkerken, et al.
Pages: 699-709
- Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group(2013)
Authors: C. Fernández De Larrea, Robert Kyle, Brian Durie, Heinz Ludwig, S Usmani, Dh Vesole, Jésus F. San Miguel, Orthan Sezer, Pieter Sonneveld, Sk Kumar, et al.
Pages: 780-791
- In vitro expanded bone marrow-derived murine (C57Bl/KaLwRij) mesenchymal stem cells can acquire CD34 expression and induce sarcoma formation in vivo.(2012)
Authors: Song Xu, Ann De Becker, Hendrik De Raeve, Benjamin Van Camp, Karin Vanderkerken, Ivan Van Riet
Pages: 391-397
- Impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients is associated with a blockade in the deactivation of the Notch signaling pathway(2012)
Authors: Song Xu, Holly R. Evans, Clive H. Buckle, Kim De Veirman, Jinsong Hu, Dehui Xu, Eline Menu, Ann De Becker, Isabelle Vande Broek, Xavier Leleu, et al.
Pages: 2546-2549
- The HDAC inhibitor LBH589 enhances the anti-myeloma effects of the IGF-1 RTK inhibitor picropodophyllin(2012)
Authors: Miguel Lemaire, C. Fristedt, P. Agarwal, Eline Menu, E Van Valckenborgh, Elke De Bruyne, Anders Österborg, Peter Atadja, Olle Larsson, Magnus Axelson, et al.
Pages: 2230-2239
- Bone Marrow Derived Mesenchymal Stromal Cells are Attracted by Multiple Myeloma Cell-Produced Chemokine CCL25 and Favor Myeloma Cell Growth In Vitro and In Vivo(2012)
Authors: Song Xu, Eline Menu, Ann De Becker, Benjamin Van Camp, Karin Vanderkerken, Ivan Van Riet
Pages: 266-279